Company Advanced Proteome Therapeutics Corporation
Equities
APC.H
CA0076282098
Investment Holding Companies
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/18/16 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10/09/10 |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21/22/21 |
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/18/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,127,080 | 36,950,363 ( 89.84 %) | 0 | 89.84 % |
Company contact information
Advanced Proteome Therapeutics Corp.
8337 Eastlake Drive Suite 104
V5A 4W2, Burnaby
+(604) 690-3797
1st Jan change | Capi. | |
---|---|---|
-.--% | 151K | |
+191.37% | 6.97B | |
+5.09% | 1.04B | |
+2.10% | 982M | |
+41.91% | 872M | |
+24.45% | 814M | |
+11.31% | 675M | |
+1.72% | 664M | |
+0.00% | 600M | |
+3.61% | 503M |
- Stock Market
- Equities
- APC.H Stock
- Company Advanced Proteome Therapeutics Corporation